Measurement of high-molecular-weight adiponectin is not useful in assessing coronary stenosis

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 4, 2012, Pages 741-745

  Imatoh, Takuya ^a   Miyazaki, Motonobu ^b   Kadowaki, Ken ^c   Tanihara, Shinichi ^a   Akashi, Chinami ^d   Une, Hiroshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b National Institute of Health Sciences   (Japan)

^c National Hospital Organization   (Japan)

^d UNIVERSITY OF NAGASAKI   (Japan)

Author keywords

coronary stenosis; epidemiology; high molecular weight adiponectin

Indexed keywords

ADIPONECTIN; HIGH MOLECULAR WEIGHT ADIPONECTIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC;

ADIPONECTIN; CASE-CONTROL STUDIES; CORONARY STENOSIS; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; ROC CURVE;

EID: 84860438956     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm.2011.832     Document Type: Article

References (24)

1. Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003;88:3236-40. (Pubitemid 36877499)
2. Ballantyne CM, Nambi V. Markers of infl ammation and their clinical signifi cance. Atheroscler (Suppl)2005;6:21-9.
3. Duncan BB, Schmidt MI, Pankow JS, Bang H, Couper D, Ballantyne CM, et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004;53:2473-8. (Pubitemid 39145606)
4. Daimon M. Oizumi T. Saitoh T. Kameda W. Hirata A. Yamaguchi H. et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: The Funagata study Diabetes Care 2003 26 2015-20. (Pubitemid 41184244)
5. Rothenbacher D, Brenner H, Marz W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J 2005;26:1640 - 6. (Pubitemid 41389695)
6. Imatoh T, Miyazaki M, Kadowaki K, Babazono A, Sato M, Une H. Interaction of low serum adiponectin levels and smoking on coronary stenosis in Japanese men. Int J Cardiol 2006;110: 251-5.
7. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 2003;278:9073-85.
8. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 2003;278:40352-63.
9. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006;29:1357-62. (Pubitemid 44125935)
10. Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, et al. High molecular weight adiponectin as a predictor of longterm clinical outcome in patients with coronary artery disease. Am J Cardiol 2007;100:569-74. (Pubitemid 47223129)
11. Katsuki A, Suematsu M, Gabazza EC, Murashima S, Nakatani K, Togashi K, et al. Decreased high-molecular weight adiponectinto- total adiponectin ratio in sera is associated with insulin resistance in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Care 2006;29:2327-8. (Pubitemid 44899878)
12. Torigoe M, Matsui H, Ogawa Y, Murakami H, Murakami R, Cheng XW, et al. Impact of the high-molecular-weight form of adiponectin on endothelial function in healthy young men. Clin Endocrinol (Oxf) 2007;67:276-81. (Pubitemid 47076306)
13. von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, et al. High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 2008;199:123-8. (Pubitemid 351842696)
14. Liang KW, Lee WJ, Lee WL, Ting CT, Sheu WH. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chim Acta 2009;405:114-8.
15. Krzyzanowska K, Aso Y, Mittermayer F, Inukai T, Brix J, Schernthaner G. High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes. Transl Res 2009;153:199-203.
16. Ogorodnikova AD, Wassertheil-Smoller S, Mancuso P, Sowers MR, Rajpathak SN, Allison MA, et al. High-molecular-weight adiponectin and incident ischemic stroke in postmenopausal women: a Women's Health Initiative Study. Stroke 2010;41: 1376-81.
17. Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, et al. Clinical signifi cance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J 2008;72:23-8. (Pubitemid 351413321)
18. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006;55:1954-60. (Pubitemid 44509967)
19. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J 2008;29:1307-15. (Pubitemid 351768129)
20. Rizza S, Clementi F, Porzio O, Cardellini M, Savo A, Serino M, et al. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr Metab Cardiovasc Dis 2009;19:54-60.
21. Seino Y, Hirose H, Saito I, Itoh H. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 2007;56:1493-9. (Pubitemid 47562499)
22. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006;91:3873-7. (Pubitemid 44536857)
23. Foucan L, Ezourhi N, Maimaitiming S, Hedreville S, Inamo J, Atallah A, et al. Adiponectin multimers and ADIPOQ T45G in coronary artery disease in Caribbean type 2 diabetic subjects of African descent. Obesity (Silver Spring) 2010;18:1466-8.
24. Rizza S, Gigli F, Galli A, Micchelini B, Lauro D, Lauro R, et al. Adiponectin isoforms in elderly patients with or without coronary artery disease. J Am Geriatr Soc 2010;58:702-6.